Literature DB >> 7944051

Body weight and bone mineral density in postmenopausal women with primary hyperparathyroidism.

A B Grey1, M C Evans, J P Stapleton, I R Reid.   

Abstract

OBJECTIVE: To assess bone mineral density and body composition in postmenopausal women with primary hyperparathyroidism.
DESIGN: Cross-sectional study with an age-matched control group.
SETTING: University teaching hospital. PATIENTS: 41 postmenopausal women with mild primary hyperparathyroidism and 43 eucalcemic, age-matched controls. MEASUREMENTS: Total body, lumbar spine, and proximal femoral (femoral neck, Ward's triangle, and trochanter) bone mineral density; body composition; and fat distribution were measured using dual-energy x-ray absorptiometry.
RESULTS: Women with primary hyperparathyroidism were heavier (75.5 kg compared with 66.3 kg; difference, 9.2 kg [95% CI, 3.7 to 14.7 kg]; P = 0.002), had a higher fat mass (33.3 kg compared with 26.1 kg; difference, 7.2 kg [CI, 3.0 to 11.4 kg]; P = 0.001), and had a more android pattern of fat distribution (android-to-gynoid fat ratio, 1.05 compared with 0.84; difference, 0.21 [CI, 0.1 to 0.32]; P = 0.0004) than the controls. Unadjusted bone mineral density was similar in patients and controls at all sites: total body, 0.990 compared with 1.023 g/cm2 (difference, 0.033; CI, -0.004 to 0.070); posteroanterior lumbar spine, 1.032 compared with 1.018 g/cm2 (difference, 0.014; CI, -0.031 to 0.059); lateral lumbar spine, 0.569 compared with 0.528 g/cm2 (difference, 0.041; CI, -0.022 to 0.104); femoral neck, 0.799 compared with 0.825 g/cm2 (difference, 0.026; CI, -0.072 to 0.124); Ward's triangle, 0.653 compared with 0.677 g/cm2 (difference, 0.024; CI, -0.035 to 0.089); trochanter, 0.734 compared with 0.733 g/cm2 (difference, 0.001; CI, -0.024 to 0.026); and arms, 0.720 compared with 0.739 g/cm2 (difference, 0.019; CI, -0.015 to 0.053). After adjustment for body weight, bone mineral density in women with primary hyperparathyroidism was lower than that in controls for total body (P = 0.0004), femoral neck (P = 0.001), Ward's triangle (P = 0.01), trochanter (P = 0.02), and arms (P = 0.0006). Spinal bone mineral density did not differ between groups.
CONCLUSIONS: Body weight, total body fat mass, and proportion of android fat are increased in postmenopausal women with primary hyperparathyroidism; these unexplained factors may be relevant to the increased incidence of cardiovascular disease in this condition. Unadjusted bone mineral density values are similar in patients with primary hyperparathyroidism and in controls, suggesting that this condition is not associated with an increased risk for fracture.

Entities:  

Mesh:

Year:  1994        PMID: 7944051     DOI: 10.7326/0003-4819-121-10-199411150-00003

Source DB:  PubMed          Journal:  Ann Intern Med        ISSN: 0003-4819            Impact factor:   25.391


  12 in total

1.  An inverted U-shaped relationship between parathyroid hormone and body weight, body mass index, body fat.

Authors:  Tian-Jiao Yuan; Liu-Ping Chen; Ya-Ling Pan; Yong Lu; Li-Hao Sun; Hong-Yan Zhao; Wei-Qing Wang; Bei Tao; Jian-Min Liu
Journal:  Endocrine       Date:  2021-02-06       Impact factor: 3.633

2.  Severe obesity is associated with symptomatic presentation, higher parathyroid hormone levels, and increased gland weight in primary hyperparathyroidism.

Authors:  Mohamed Abdelgadir Adam; Brian R Untch; Melissa E Danko; Sandra Stinnett; Darshana Dixit; James Koh; Jeffrey R Marks; John A Olson
Journal:  J Clin Endocrinol Metab       Date:  2010-08-04       Impact factor: 5.958

Review 3.  Bone Involvement in Primary Hyperparathyroidism and Changes After Parathyroidectomy.

Authors:  Lars Rolighed; Lars Rejnmark; Peer Christiansen
Journal:  Eur Endocrinol       Date:  2014-02-28

4.  Effect of gender and geographic location on the expression of primary hyperparathyroidism.

Authors:  F De Lucia; S Minisola; E Romagnoli; J Pepe; C Cipriani; A Scillitani; N Parikh; D S Rao
Journal:  J Endocrinol Invest       Date:  2012-06-18       Impact factor: 4.256

5.  Using QCT to evaluate bone mineral and abdominal adipose changes in patients with primary hyperparathyroidism and comparing it to DXA for bone status assessment: a retrospective case-control study.

Authors:  Liuping Chen; Yaling Pan; Fangyuan Zhong; Tian-Jiao Yuan; Hanqi Wang; Tongtong Chen; Haiying Lv; Xiaoguang Cheng; Jian-Min Liu; Yong Lu
Journal:  Ann Transl Med       Date:  2022-05

6.  Diagnosis of normocalcemic hyperparathyroidism by oral calcium loading test.

Authors:  P Hagag; I Revet-Zak; N Hod; T Horne; M J Rapoport; M Weiss
Journal:  J Endocrinol Invest       Date:  2003-04       Impact factor: 4.256

7.  Trabecular Bone Score in Obese and Nonobese Subjects With Primary Hyperparathyroidism Before and After Parathyroidectomy.

Authors:  Yu-Kwang Donovan Tay; Natalie E Cusano; Mishaela R Rubin; John Williams; Beatriz Omeragic; John P Bilezikian
Journal:  J Clin Endocrinol Metab       Date:  2018-04-01       Impact factor: 5.958

8.  Cardiovascular risk factors in primary hyperparathyroidism.

Authors:  R Luboshitzky; Y Chertok-Schaham; I Lavi; A Ishay
Journal:  J Endocrinol Invest       Date:  2009-04       Impact factor: 4.256

Review 9.  Effects of calcium supplementation on circulating lipids: potential pharmacoeconomic implications.

Authors:  Ian R Reid
Journal:  Drugs Aging       Date:  2004       Impact factor: 3.923

10.  Body Size and the Risk of Primary Hyperparathyroidism in Women: A Cohort Study.

Authors:  Anand Vaidya; Gary C Curhan; Julie M Paik; Molin Wang; Eric N Taylor
Journal:  J Bone Miner Res       Date:  2017-06-12       Impact factor: 6.741

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.